Pages with the fewest revisions

Showing below up to 250 results in range #1 to #250.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

1. Marrow cellularity‏‎ (1 revision)
2. Multitarget equation‏‎ (1 revision)
3. Acute exposure‏‎ (1 revision)
4. Allometry‏‎ (1 revision)
5. Pilomatricoma‏‎ (1 revision)
6. ICRP Publication 102‏‎ (1 revision)
7. ICRP Publication 116‏‎ (1 revision)
8. Radiation-induced secondary malignancy‏‎ (1 revision)
9. ICRP Publication 130‏‎ (1 revision)
10. Radiological attack‏‎ (1 revision)
11. ICRP Publication 145‏‎ (1 revision)
12. Reactive oxygen species‏‎ (1 revision)
13. ICRP Publication 2‏‎ (1 revision)
14. Reference worker‏‎ (1 revision)
15. ICRP Publication 30 (Part 3)‏‎ (1 revision)
16. Derived consideration reference level‏‎ (1 revision)
17. ICRP Publication 92‏‎ (1 revision)
18. ICRP Publication 40‏‎ (1 revision)
19. ICRP Publication 55‏‎ (1 revision)
20. Dose conversion convention‏‎ (1 revision)
21. Informed consent‏‎ (1 revision)
22. ICRP Publication 7‏‎ (1 revision)
23. Spongiosa‏‎ (1 revision)
24. ICRP Publication 84‏‎ (1 revision)
25. Exclusion‏‎ (1 revision)
26. Time-resolved computed tomography‏‎ (1 revision)
27. Mutation component‏‎ (1 revision)
28. Waste management‏‎ (1 revision)
29. Normal tissue complication probability‏‎ (1 revision)
30. Biological half-life‏‎ (1 revision)
31. ICRP Publication 117‏‎ (1 revision)
32. ICRP Publication 131‏‎ (1 revision)
33. Radiological controlled area‏‎ (1 revision)
34. ICRP Publication 146‏‎ (1 revision)
35. Concentration ratio‏‎ (1 revision)
36. ICRP Publication 20‏‎ (1 revision)
37. Referrer‏‎ (1 revision)
38. ICRP Publication 30 (Part 4)‏‎ (1 revision)
39. Derived investigation level‏‎ (1 revision)
40. ICRP Publication 93‏‎ (1 revision)
41. ICRP Publication 41‏‎ (1 revision)
42. Directional dose equivalent‏‎ (1 revision)
43. ICRU 4-element tissue‏‎ (1 revision)
44. ICRP Publication 56‏‎ (1 revision)
45. Dose conversion factor‏‎ (1 revision)
46. ICRP Publication 70‏‎ (1 revision)
47. Effect modifier‏‎ (1 revision)
48. ICRP Publication 85‏‎ (1 revision)
49. Endosteum‏‎ (1 revision)
50. System of radiological protection‏‎ (1 revision)
51. Treatment preparation in radiotherapy‏‎ (1 revision)
52. Notification value‏‎ (1 revision)
53. Other (systemic) tissues‏‎ (1 revision)
54. Human Alimentary Tract Model‏‎ (1 revision)
55. ICRP Publication 104‏‎ (1 revision)
56. Biomarker‏‎ (1 revision)
57. ICRP Publication 132‏‎ (1 revision)
58. Clonogenic surviving fraction‏‎ (1 revision)
59. ICRP Publication 147‏‎ (1 revision)
60. Cone beam computed tomography‏‎ (1 revision)
61. ICRP Publication 21‏‎ (1 revision)
62. Region‏‎ (1 revision)
63. ICRP Publication 30 (Supplement A to Part 3)‏‎ (1 revision)
64. Derived limit‏‎ (1 revision)
65. ICRP Publication 94‏‎ (1 revision)
66. ICRP Publication 42‏‎ (1 revision)
67. ICRU sphere‏‎ (1 revision)
68. ICRP Publication 57‏‎ (1 revision)
69. ICRP Publication 71‏‎ (1 revision)
70. ICRP Publication 86‏‎ (1 revision)
71. Mean glandular dose‏‎ (1 revision)
72. Absorption Type‏‎ (1 revision - redirect page)
73. Trophic level‏‎ (1 revision)
74. Additional dose‏‎ (1 revision)
75. Nuclear medicine‏‎ (1 revision)
76. Ambient dose equivalent‏‎ (1 revision)
77. Human Respiratory Tract Model‏‎ (1 revision)
78. Automatic exposure control‏‎ (1 revision)
79. Pooled analysis‏‎ (1 revision)
80. ICRP Publication 105‏‎ (1 revision)
81. ICRP Publication 119‏‎ (1 revision)
82. Radiation risk‏‎ (1 revision)
83. ICRP Publication 133‏‎ (1 revision)
84. ICRP Publication 148‏‎ (1 revision)
85. ICRP Publication 22‏‎ (1 revision)
86. Regional diagnostic reference levels‏‎ (1 revision)
87. ICRP Publication 30 (Supplement B to Part 3)‏‎ (1 revision)
88. Derived reference level‏‎ (1 revision)
89. ICRP Publication 95‏‎ (1 revision)
90. ICRP Publication 43‏‎ (1 revision)
91. Disposal facility‏‎ (1 revision)
92. Sealed source‏‎ (1 revision)
93. ICRP Publication 58‏‎ (1 revision)
94. Solar flare‏‎ (1 revision)
95. ICRP Publication 72‏‎ (1 revision)
96. ICRP Publication 87‏‎ (1 revision)
97. Linear dose response‏‎ (1 revision)
98. 1928 Recommendations‏‎ (1 revision)
99. Tissue reaction‏‎ (1 revision)
100. Measured quantity‏‎ (1 revision)
101. Tumour suppressor gene‏‎ (1 revision)
102. National DRL‏‎ (1 revision)
103. Additive risk projection model‏‎ (1 revision)
104. Oxygen enhancement ratio‏‎ (1 revision)
105. Population risk‏‎ (1 revision)
106. ICRP Publication 106‏‎ (1 revision)
107. ICRP Publication 12‏‎ (1 revision)
108. ICRP Publication 134‏‎ (1 revision)
109. Cobblestone area forming cell assay‏‎ (1 revision)
110. ICRP Publication 149‏‎ (1 revision)
111. ICRP Publication 23‏‎ (1 revision)
112. DRL quantity‏‎ (1 revision)
113. Registry‏‎ (1 revision)
114. ICRP Publication 30 (Supplement to Part 1)‏‎ (1 revision)
115. Designated area‏‎ (1 revision)
116. ICRP Publication 96‏‎ (1 revision)
117. ICRP Publication 44‏‎ (1 revision)
118. Distribution coefficient‏‎ (1 revision)
119. Secondary radiation‏‎ (1 revision)
120. ICRP Publication 59‏‎ (1 revision)
121. Intake‏‎ (1 revision)
122. ICRP Publication 73‏‎ (1 revision)
123. Standard-size adult‏‎ (1 revision)
124. ICRP Publication 88‏‎ (1 revision)
125. Epigenetic effects‏‎ (1 revision)
126. Exogenous excretion‏‎ (1 revision)
127. 1931 Recommendations‏‎ (1 revision)
128. National radon survey‏‎ (1 revision)
129. Adenoma‏‎ (1 revision)
130. Potential alpha energy concentration‏‎ (1 revision)
131. ICRP Publication 107‏‎ (1 revision)
132. ICRP Publication 120‏‎ (1 revision)
133. Carers and comforters‏‎ (1 revision)
134. ICRP Publication 135‏‎ (1 revision)
135. ICRP Publication 15‏‎ (1 revision)
136. Redox‏‎ (1 revision)
137. ICRP Publication 24‏‎ (1 revision)
138. ICRP Publication 30 (Supplement to Part 2)‏‎ (1 revision)
139. Detector quantum efficiency‏‎ (1 revision)
140. ICRP Publication 97‏‎ (1 revision)
141. ICRP Publication 45‏‎ (1 revision)
142. Secretory cells‏‎ (1 revision)
143. ICRP Publication 6‏‎ (1 revision)
144. Intensity-modulated radiotherapy‏‎ (1 revision)
145. ICRP Publication 74‏‎ (1 revision)
146. Stem cell‏‎ (1 revision)
147. Kerma approximation‏‎ (1 revision)
148. ICRP Publication 89‏‎ (1 revision)
149. 1934 Recommendations‏‎ (1 revision)
150. Access control‏‎ (1 revision)
151. Typical value‏‎ (1 revision)
152. General Information: Radon‏‎ (1 revision - redirect page)
153. Particle transport‏‎ (1 revision)
154. ICRP Publication 108‏‎ (1 revision)
155. Brachytherapy‏‎ (1 revision)
156. ICRP Publication 121‏‎ (1 revision)
157. Case–control study‏‎ (1 revision)
158. ICRP Publication 136‏‎ (1 revision)
159. Collective dose‏‎ (1 revision)
160. ICRP Publication 150‏‎ (1 revision)
161. ICRP Publication 25‏‎ (1 revision)
162. Relative biological effectiveness‏‎ (1 revision)
163. ICRP Publication 31‏‎ (1 revision)
164. Deterministic effect‏‎ (1 revision)
165. ICRP Publication 98‏‎ (1 revision)
166. ICRP Publication 46‏‎ (1 revision)
167. ICRP Publication 60‏‎ (1 revision)
168. Dose modifying factor‏‎ (1 revision)
169. Somatic effect‏‎ (1 revision)
170. ICRP Publication 75‏‎ (1 revision)
171. ICRP Publication 9‏‎ (1 revision)
172. Targeted effects‏‎ (1 revision)
173. Expanded radiation field‏‎ (1 revision)
174. 1937 Recommendations‏‎ (1 revision)
175. Tolerance dose‏‎ (1 revision)
176. Adventitious source‏‎ (1 revision)
177. Occupancy factor‏‎ (1 revision)
178. Annual intake‏‎ (1 revision)
179. ICRP Publication 109‏‎ (1 revision)
180. ICRP Publication 122‏‎ (1 revision)
181. ICRP Publication 137‏‎ (1 revision)
182. Radon-prone area‏‎ (1 revision)
183. ICRP Publication 151‏‎ (1 revision)
184. Reference Person‏‎ (1 revision)
185. ICRP Publication 26‏‎ (1 revision)
186. DS86‏‎ (1 revision)
187. Relative life lost‏‎ (1 revision)
188. ICRP Publication 32‏‎ (1 revision)
189. ICRP Publication 99‏‎ (1 revision)
190. ICRP Publication 47‏‎ (1 revision)
191. Security screening‏‎ (1 revision)
192. ICRP Publication 61‏‎ (1 revision)
193. ICRP Publication 76‏‎ (1 revision)
194. Stochastic effect‏‎ (1 revision)
195. Equilibrium equivalent concentration‏‎ (1 revision)
196. 1950 Recommendations‏‎ (1 revision)
197. Backscatter factor‏‎ (1 revision)
198. Potentially lethal damage repair‏‎ (1 revision)
199. ICRP Publication 10A‏‎ (1 revision)
200. ICRP Publication 123‏‎ (1 revision)
201. Charged-particle equilibrium‏‎ (1 revision)
202. ICRP Publication 138‏‎ (1 revision)
203. Collimation‏‎ (1 revision)
204. ICRP Publication 152‏‎ (1 revision)
205. ICRP Publication 27‏‎ (1 revision)
206. Relative risk‏‎ (1 revision)
207. ICRP Publication 33‏‎ (1 revision)
208. Detriment-adjusted risk‏‎ (1 revision)
209. Ring chromosome‏‎ (1 revision)
210. ICRP Supporting Guidance 2‏‎ (1 revision)
211. ICRP Publication 48‏‎ (1 revision)
212. Dose-response function‏‎ (1 revision)
213. ICRP Publication 62‏‎ (1 revision)
214. International Commission on Radiological Protection‏‎ (1 revision)
215. ICRP Publication 77‏‎ (1 revision)
216. Lag‏‎ (1 revision)
217. Equilibrium factor‏‎ (1 revision)
218. Teratocarcinoma‏‎ (1 revision)
219. Low dose‏‎ (1 revision)
220. Exposed individuals‏‎ (1 revision)
221. 1954 Recommendations‏‎ (1 revision)
222. Α/β value‏‎ (1 revision)
223. Oncogene‏‎ (1 revision)
224. Apoptosis‏‎ (1 revision)
225. ICRP Publication 11‏‎ (1 revision)
226. ICRP Publication 124‏‎ (1 revision)
227. ICRP Publication 139‏‎ (1 revision)
228. ICRP Publication 153‏‎ (1 revision)
229. ICRP Publication 28‏‎ (1 revision)
230. Relative survival‏‎ (1 revision)
231. ICRP Publication 34‏‎ (1 revision)
232. ICRP Publication 49‏‎ (1 revision)
233. ICRP Publication 63‏‎ (1 revision)
234. Source region‏‎ (1 revision)
235. ICRP Publication 78‏‎ (1 revision)
236. Elemental dose‏‎ (1 revision)
237. Late normal tissue responses‏‎ (1 revision)
238. 1956 Recommendations‏‎ (1 revision)
239. Transfer of risk‏‎ (1 revision)
240. Molecular imaging‏‎ (1 revision)
241. Activation‏‎ (1 revision)
242. Noise‏‎ (1 revision)
243. ΓH2AX foci‏‎ (1 revision)
244. Operating management‏‎ (1 revision)
245. Pencil beam‏‎ (1 revision)
246. ICRP Publication 1‏‎ (1 revision)
247. Baseline disease rates‏‎ (1 revision)
248. Practice‏‎ (1 revision)
249. ICRP Publication 110‏‎ (1 revision)
250. Breakpoint cluster region/abelson‏‎ (1 revision)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)